| APOBEC3A damages the cellular genome during DNA replication AM Green, S Landry, K Budagyan, DC Avgousti, S Shalhout, AS Bhagwat, ... Cell cycle 15 (7), 998-1008, 2016 | 92 | 2016 |
| The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities AM Green, MD Weitzman DNA repair 83, 102700, 2019 | 66 | 2019 |
| The 5 minute pediatric consult MW Schwartz Lippincott Williams & Wilkins, 2012 | 57 | 2012 |
| Cytosine deaminase APOBEC3A sensitizes leukemia cells to inhibition of the DNA replication checkpoint AM Green, K Budagyan, KE Hayer, MA Reed, MR Savani, GB Wertheim, ... Cancer research 77 (17), 4579-4588, 2017 | 55 | 2017 |
| Controllable genome editing with split-engineered base editors KN Berríos, NH Evitt, RA DeWeerd, D Ren, M Luo, A Barka, T Wang, ... Nature chemical biology 17 (12), 1262-1270, 2021 | 34 | 2021 |
| Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers RA DeWeerd, E Németh, Á Póti, N Petryk, CL Chen, O Hyrien, D Szüts, ... Cell reports 38 (12), 2022 | 31 | 2022 |
| Fungal infections in children with haematologic malignancies and stem cell transplant recipients WR Otto, AM Green British journal of haematology 189 (4), 607-624, 2020 | 31 | 2020 |
| Antigen glycosylation regulates efficacy of CAR T cells targeting CD19 A Heard, JH Landmann, AR Hansen, A Papadopolou, YS Hsu, ME Selli, ... Nature communications 13 (1), 3367, 2022 | 28 | 2022 |
| Addressing the benefits of inhibiting APOBEC3-dependent mutagenesis in cancer M Petljak, AM Green, J Maciejowski, MD Weitzman Nature genetics 54 (11), 1599-1608, 2022 | 23 | 2022 |
| Utility of unenhanced fat-suppressed T1-weighted MRI in children with sickle cell disease—can it differentiate bone infarcts from acute osteomyelitis? J Delgado, MA Bedoya, AM Green, D Jaramillo, V Ho-Fung Pediatric radiology 45, 1981-1987, 2015 | 21 | 2015 |
| Invasive Curvularia Infection in Pediatric Patients With Hematologic Malignancy Identified by Fungal Sequencing YC Chang, E Graf, AM Green Journal of the Pediatric Infectious Diseases Society 8 (1), 87-91, 2019 | 16 | 2019 |
| Interaction with the CCT chaperonin complex limits APOBEC3A cytidine deaminase cytotoxicity AM Green, RA DeWeerd, DR O’Leary, AR Hansen, KE Hayer, K Kulej, ... EMBO reports 22 (9), e52145, 2021 | 6 | 2021 |
| Antiviral therapeutics in pediatric transplant recipients WR Otto, A Green Infectious disease clinics of North America 36 (1), 125-146, 2022 | 5 | 2022 |
| Nuclease‐independent functions of RAG1 direct distinct DNA damage responses in B cells R Johnston, B Mathias, SJ Crowley, HA Schmidt, LS White, ... EMBO reports 24 (1), e55429, 2023 | 4 | 2023 |
| Fdg-pet in two cases of neurofibromatosis type 1 and atypical malignancies P De Blank, K Cole, L Kersun, A Green, JJ Wilkes, J Belasco, R Bagatell, ... Current Oncology 21 (2), 345-348, 2014 | 3 | 2014 |
| MYSM1 attenuates DNA damage signals triggered by physiologic and genotoxic DNA breaks B Mathias, D O’Leary, N Saucier, F Ahmad, LS White, M Shinawi, ... Journal of Allergy and Clinical Immunology 153 (4), 1113-1124. e7, 2024 | 1 | 2024 |
| Virus-Specific T Cells for the Treatment of Systemic Infections Following Allogeneic Hematopoietic Cell and Solid Organ Transplantation A Green, JD Rubinstein, M Grimley, T Pfeiffer Journal of the Pediatric Infectious Diseases Society 13 (Supplement_1), S49-S57, 2024 | 1 | 2024 |
| Antigen glycosylation is a central regulator of CAR T cell efficacy A Heard, ME Selli, J Lattin, J Landmann, J Chang, H Ha, B Doray, ... Blood 138, 1721, 2021 | 1 | 2021 |
| Interpretation and management of positive anti‐hepatitis B core antibody tests in immunocompromised pediatric patients E Kitt, M Hayes, AM Cárdenas, AM Green Transplant Infectious Disease 21 (3), e13074, 2019 | 1 | 2019 |
| APOBEC3 activity sensitizes cells to ATR-Chk1 pathway inhibition K Budagyan, MD Weitzman, AM Green Cancer Research 76 (14_Supplement), 3579-3579, 2016 | 1 | 2016 |
Katharina E HayerBioinformatics Scientist III, DBHi, Children's Hospital of PhiladelphiaVerified email at EMAIL.CHOP.EDU
